KPX Lifescience.Co.Ltd - Asset Resilience Ratio

Latest as of September 2025: 7.59%

KPX Lifescience.Co.Ltd (114450) has an Asset Resilience Ratio of 7.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does KPX Lifescience.Co.Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

₩3.82 Billion

≈ $2.59 Million USD Cash + Short-term Investments

Total Assets

₩50.34 Billion

≈ $34.12 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how KPX Lifescience.Co.Ltd's Asset Resilience Ratio has changed over time. See 114450 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down KPX Lifescience.Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of KPX Lifescience.Co.Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩3.82 Billion	7.59%
Total Liquid Assets	₩3.82 Billion	7.59%

Asset Resilience Insights

Limited Liquidity: KPX Lifescience.Co.Ltd maintains only 7.59% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

KPX Lifescience.Co.Ltd Industry Peers by Asset Resilience Ratio

Compare KPX Lifescience.Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Kolon Life Science Inc KQ:102940	Pharmaceuticals	1.22%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%

Annual Asset Resilience Ratio for KPX Lifescience.Co.Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for KPX Lifescience.Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	28.65%	₩12.89 Billion ≈ $8.73 Million	₩44.97 Billion ≈ $30.48 Million	-4.32pp
2023-12-31	32.98%	₩14.45 Billion ≈ $9.79 Million	₩43.83 Billion ≈ $29.70 Million	+6.31pp
2022-12-31	26.67%	₩16.65 Billion ≈ $11.28 Million	₩62.43 Billion ≈ $42.31 Million	+4.57pp
2021-12-31	22.10%	₩15.90 Billion ≈ $10.78 Million	₩71.98 Billion ≈ $48.78 Million	+1.16pp
2020-12-31	20.94%	₩14.83 Billion ≈ $10.05 Million	₩70.85 Billion ≈ $48.01 Million	-3.14pp
2019-12-31	24.07%	₩17.31 Billion ≈ $11.73 Million	₩71.89 Billion ≈ $48.72 Million	+5.27pp
2018-12-31	18.80%	₩13.04 Billion ≈ $8.84 Million	₩69.37 Billion ≈ $47.01 Million	-13.64pp
2017-12-31	32.44%	₩23.67 Billion ≈ $16.04 Million	₩72.96 Billion ≈ $49.45 Million	-2.05pp
2016-12-31	34.48%	₩26.57 Billion ≈ $18.01 Million	₩77.06 Billion ≈ $52.22 Million	+18.98pp
2015-12-31	15.50%	₩10.41 Billion ≈ $7.05 Million	₩67.15 Billion ≈ $45.51 Million	-0.61pp
2014-12-31	16.11%	₩10.70 Billion ≈ $7.25 Million	₩66.43 Billion ≈ $45.02 Million	--

pp = percentage points

About KPX Lifescience.Co.Ltd

KQ:114450 Korea Pharmaceuticals

Market Cap

$29.38 Million

₩43.35 Billion KRW

Market Cap Rank

#23772 Global

#1714 in Korea

Share Price

₩2890.00

Change (1 day)

-1.37%

52-Week Range

₩1589.00 - ₩4065.00

All Time High

₩20587.50